Shivalik Rasayan

Why is Shivalik Rasayan Ltd falling/rising?

As of 24-Jun, Shivalik Rasayan Ltd's stock price is Rs 210.75, down 3.79%, with significant declines over the past week, month, and year. The stock is near its 52-week low and shows a bearish trend, reflecting a lack of investor confidence despite a recent increase in delivery volume.

As of 24-Jun, Shivalik Rasayan Ltd's stock price is falling, currently at Rs 210.75, which reflects a decrease of Rs 8.3 or 3.79%. The stock has been underperforming significantly, with a 1-week decline of 5.45% compared to a minimal drop of 0.21% in the Sensex. Over the past month, the stock has decreased by 18.31%, while the Sensex has gained 2.09%. Year-to-date, the stock is down 40.78%, contrasting with a 9.66% decline in the benchmark index.<BR><BR>The stock is also close to its 52-week low, just 1.33% above Rs 207.7, and has experienced consecutive losses over the last two days, totaling a decline of 4.27%. Today, it reached an intraday low of Rs 210.5, indicating persistent downward pressure. Additionally, Shivalik Rasayan is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend.<BR><BR>Despite some positive signs, such as a significant increase in delivery volume by 113.01% on June 23, the overall performance indicates a lack of investor confidence, leading to the stock's decline. The liquidity remains adequate for trading, but the overall negative performance metrics highlight the reasons for the stock's falling price.

Which are the latest news on Shivalik Rasayan?

How big is Shivalik Rasayan?

As of 10th June, Shivalik Rasayan Ltd has a market capitalization of 374.00 Cr, with recent net sales of 368.01 Cr and a net profit of 11.88 Cr. Shareholder's funds are 536.24 Cr and total assets amount to 727.73 Cr as of March 2025.

As of 10th June, Shivalik Rasayan Ltd has a market capitalization of 374.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Shivalik Rasayan reported Net Sales of 368.01 Cr and a Net Profit of 11.88 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 536.24 Cr and Total Assets of 727.73 Cr.

Who are in the management team of Shivalik Rasayan?

The management team of Shivalik Rasayan includes key members such as Rahul Bishnoi (Chairman), Vimal Kumar Shrawat (Managing Director), and several independent directors, overseeing the company's strategic direction and operations.

The management team of Shivalik Rasayan includes the following members:<BR><BR>1. **Rahul Bishnoi** - Chairman<BR>2. **S K Singh** - Vice Chairman & Whole Time Director<BR>3. **Ashwani Kumar Sharma** - Director<BR>4. **Harish Pande** - Independent Director<BR>5. **Kailash Gupta** - Independent Director<BR>6. **Arun Kumar** - Independent Director<BR>7. **Akshay Kant Chaturvedi** - Executive Director<BR>8. **Sanjay Bansal** - Director<BR>9. **Sumita Dwivedi** - Independent Director<BR>10. **Parul Choudhary** - Company Secretary<BR>11. **Sangeeta Bishnoi** - Independent Director<BR>12. **Ravi Kumar Bansal** - Independent Director<BR>13. **Vimal Kumar Shrawat** - Managing Director<BR><BR>This team is responsible for the strategic direction and management of the company.

Who are the peers of the Shivalik Rasayan?

Shivalik Rasayan's peers include Dharmaj Crop, Heranba Inds, Best Agrolife, and others. While Dharmaj Crop shows excellent management and growth, Shivalik Rasayan has a below-average growth rate and a significantly lower 1-year return of -57.22%.

Peers: The peers of Shivalik Rasayan are Dharmaj Crop, Heranba Inds, Best Agrolife, Crop Life Scienc, Aristo Bio-Tech, Dhansa Labs, Bhaskar Agrochem, and Aimco Pesticides.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dharmaj Crop and Bhaskar Agrochem, while Average management risk is found at Heranba Inds, Crop Life Scienc, Aristo Bio-Tech, and the rest. Good growth is seen at Dharmaj Crop and Average growth at Aristo Bio-Tech and Bhaskar Agrochem, while Below Average growth is noted at Heranba Inds, Best Agrolife, Shivalik Rasayan, Crop Life Scienc, Dhansa Labs, Aimco Pesticides, and the rest. Excellent capital structure is attributed to Shivalik Rasayan, while Average capital structure is found at Heranba Inds, Best Agrolife, Aristo Bio-Tech, and the rest, with Below Average capital structure at Crop Life Scienc, Dhansa Labs, and Aimco Pesticides.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Dharmaj Crop at -0.74%, while the peer with the lowest is Heranba Inds at -32.55%. Shivalik Rasayan's 1-year return of -57.22% is significantly lower than both. Additionally, several peers, including Heranba Inds, Best Agrolife, Dhansa Labs, and Aimco Pesticides, have negative six-month returns.

What does Shivalik Rasayan do?

Shivalik Rasayan Ltd is a micro-cap manufacturer of organophosphate insecticides in the agrochemicals industry, with recent quarterly net sales of ₹103 Cr and a net profit of ₹5 Cr. The company also holds a 44.12% stake in Medicamen Biotech Limited.

Overview:<BR>Shivalik Rasayan Ltd is a manufacturer of organophosphate insecticides operating in the pesticides and agrochemicals industry, categorized as a micro-cap company.<BR><BR>History:<BR>Shivalik Rasayan Limited was incorporated on 16 March 1979. In 2016, the company acquired 44.12% equity shares of Medicamen Biotech Limited and took over full management control on 1st January 2016. The latest reported quarterly results indicate net sales and profit for March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 103 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 5 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 374 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 32.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 0.21%<BR>- Debt Equity: 0.13<BR>- Return on Equity: 1.98%<BR>- Price to Book: 0.62<BR><BR>Contact Details:<BR>Address: Village Kolhupani, P O Chandanwari Dehradun UTT : 248007<BR>Tel: 91-0135-2772038/2773429<BR>Email: srl@vsnl.com/srl@airtelmail.in<BR>Website: http://www.shivalikrasayan.in

Should I buy, sell or hold Shivalik Rasayan Ltd?

Are Shivalik Rasayan Ltd latest results good or bad?

Shivalik Rasayan Ltd's latest results show strong revenue growth with a 67.78% increase in net profit and a 48.18% rise in net sales, but concerns remain due to declining operating margins and a low return on equity of 2.40%. Overall, while the top-line performance is promising, challenges in profitability and efficiency may impact future sustainability.

Shivalik Rasayan Ltd's latest results present a mixed picture. On the positive side, the company reported a consolidated net profit of ₹4.53 crore for Q4 FY26, which is a significant increase of 67.78% quarter-on-quarter and 9.69% year-on-year. Additionally, net sales reached ₹102.82 crore, marking a robust growth of 25.33% from the previous quarter and an impressive 48.18% increase compared to the same quarter last year. This strong revenue growth suggests a recovery in market demand and operational momentum.<BR><BR>However, there are notable concerns. The operating margin for Q4 FY26 was 12.09%, which is slightly down from the previous quarter and significantly lower than historical highs. The return on equity (ROE) remains weak at just 2.40%, indicating challenges in generating adequate returns on shareholder capital. Furthermore, the company's stock has experienced a dramatic decline of 49.75% over the past year, reflecting broader market skepticism about its operational efficiency and profitability.<BR><BR>Overall, while the recent results show strong top-line growth, persistent margin pressures and low capital efficiency raise questions about the sustainability of this performance. Investors should weigh these factors carefully when assessing the company's outlook.

When is the next results date for Shivalik Rasayan Ltd?

The next results date for Shivalik Rasayan Ltd is 27 May 2026.

The next results date for Shivalik Rasayan Ltd is scheduled for 27 May 2026.

Is Shivalik Rasayan overvalued or undervalued?

As of December 3, 2025, Shivalik Rasayan is considered overvalued due to a high PE ratio of 44.34, an EV to EBITDA of 16.07, a low ROE of 2.40%, and significant underperformance compared to the Sensex, leading to a shift in its valuation grade from very attractive to attractive.

As of 3 December 2025, the valuation grade for Shivalik Rasayan has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently considered overvalued based on its high PE ratio of 44.34, an EV to EBITDA of 16.07, and a low ROE of 2.40%. In comparison, peers such as Godrej Industries, which has a PE ratio of 36.37 and an EV to EBITDA of 40.25, suggest that Shivalik Rasayan's valuation is on the higher end within its industry.<BR><BR>The company's financial performance also shows concerning trends, with a significant decline in stock performance relative to the Sensex over various periods, particularly a year-to-date drop of 48.36% compared to the Sensex's gain of 8.92%. This underperformance, combined with the high valuation ratios, reinforces the conclusion that Shivalik Rasayan is overvalued in the current market environment.

How has been the historical performance of Shivalik Rasayan?

Shivalik Rasayan has shown consistent growth in net sales, reaching 311.77 Cr in Mar'25, but has faced fluctuations in operating profit and a decline in profit after tax from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. Total liabilities and assets both increased to 727.73 Cr in Mar'25, while cash flow from operating activities remains negative.

Answer:<BR>The historical performance of Shivalik Rasayan shows a consistent growth trend in net sales and total operating income over the years, reaching 311.77 Cr in Mar'25, up from 272.98 Cr in Mar'24 and 234.45 Cr in Mar'23. However, the company has faced fluctuations in operating profit, with a peak of 50.46 Cr in Mar'22, followed by a decline to 48.51 Cr in Mar'25. Profit after tax has also seen a decrease, from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. The company's total liabilities increased to 727.73 Cr in Mar'25 from 688.42 Cr in Mar'24, while total assets rose to 727.73 Cr as well, indicating a stable asset-liability balance. Cash flow from operating activities has been negative in recent years, with -9.00 Cr in Mar'25, reflecting challenges in cash generation despite positive financing activities.<BR><BR>Breakdown:<BR>Shivalik Rasayan's net sales and total operating income have shown a steady increase, with net sales rising from 186.28 Cr in Mar'20 to 311.77 Cr in Mar'25. The raw material costs have also increased significantly, contributing to total expenditure growth from 147.29 Cr in Mar'19 to 271.57 Cr in Mar'25. Operating profit, while fluctuating, peaked at 50.46 Cr in Mar'22 before declining to 48.51 Cr in Mar'25. Profit before tax has been relatively stable, with a slight increase to 23.41 Cr in Mar'25. However, profit after tax has decreased from 34.25 Cr in Mar'22 to 20.42 Cr in Mar'25. The company's total liabilities have risen alongside total assets, both reaching 727.73 Cr in Mar'25, indicating a balanced growth in financial structure. Cash flow from operating activities has been negative, highlighting ongoing challenges in cash generation despite positive inflows from financing activities.

Is Shivalik Rasayan technically bullish or bearish?

As of November 13, 2025, the technical trend is bearish with moderate strength, driven by bearish signals from moving averages and Bollinger Bands, despite a mildly bullish weekly MACD and Dow Theory outlook.

As of 13 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages, the weekly and monthly Bollinger Bands, and the KST. Although the weekly MACD shows a mildly bullish signal, it is overshadowed by the overall bearish trend in the monthly timeframe. Additionally, the Dow Theory indicates a mildly bullish weekly outlook but remains mildly bearish on the monthly scale. The stock has underperformed significantly compared to the Sensex over various periods, reinforcing the bearish sentiment.

Who are the top shareholders of the Shivalik Rasayan?

The top shareholders of Shivalik Rasayan are Growel Remedies Limited with 47.37%, individual investors with 30.62%, and Ginnerup Capital Aps holding 3.22%. There are no pledged promoter holdings, and mutual funds do not own shares in the company.

The top shareholders of Shivalik Rasayan include Growel Remedies Limited, which holds the largest stake at 47.37%. Additionally, individual investors collectively own 30.62% of the shares. Among public shareholders, Ginnerup Capital Aps has a notable holding of 3.22%. The company also has 15 foreign institutional investors (FIIs) that collectively hold 4.36% of the shares. There are no pledged promoter holdings, and mutual funds do not hold any shares in the company.

What is the bonus history of the Shivalik Rasayan?

Shivalik Rasayan issued a bonus in a 1:4 ratio on April 19, 2018, with a record date of April 20, 2018. This was the company's most recent bonus action.

Shivalik Rasayan has a bonus history that includes a significant issue announced on April 19, 2018. The company issued a bonus in the ratio of 1:4, meaning that for every four shares held, shareholders received one additional share. The record date for this bonus was April 20, 2018. This was the latest bonus action taken by the company. If you have any more questions about Shivalik Rasayan or need further details, feel free to ask!

Has Shivalik Rasayan declared dividend?

Shivalik Rasayan Ltd has declared a 10% dividend, amounting to ₹0.5 per share, with an ex-date of September 20, 2024. While the company has shown a strong total return of 121.13% over the last 5 years, recent shorter-term performance has been negative.

Shivalik Rasayan Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 0.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 0.09%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.22%, with a dividend return of 0%, resulting in a total return of -30.22%.<BR><BR>Over the past year, the price return was -6.13%, and the dividend return was 0.09%, leading to a total return of -6.04%.<BR><BR>In the 2-year period, the price return was -24.94%, with a dividend return of 0.13%, culminating in a total return of -24.81%.<BR><BR>For the 3-year period, the price return was -31.26%, while the dividend return was 0.21%, resulting in a total return of -31.05%.<BR><BR>In the 4-year period, the price return was -25.41%, with a dividend return of 0.25%, leading to a total return of -25.16%.<BR><BR>Finally, over the last 5 years, the price return was 120.38%, and the dividend return was 0.75%, resulting in a total return of 121.13%.<BR><BR>Overall, Shivalik Rasayan Ltd has declared a dividend, but the total returns over various periods show a mixed performance, with significant declines in the shorter terms and a strong recovery over the 5-year period.